MEN1 mutations mediate clinical resistance to menin inhibition
Boston Children's Hospital · Harvard University · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
236
total citations
- FWCI
- 34.23
- Percentile
- 100%
- References
- 29
Citations per year
Authors
29- FPFlorian PernerCorresponding
Boston Children's Hospital, Harvard University, Universitätsmedizin Greifswald, Dana-Farber Cancer Institute
- EMEytan M. Stein
Memorial Sloan Kettering Cancer Center
- DVDaniela V. Wenge
Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute
- SSSukrit Singh
Memorial Sloan Kettering Cancer Center
- JKJeonghyeon Kim
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Chromatin
- Biology
- Cancer research
- Mutation
- BRD4
- Gene mutation
- Somatic cell
- MEN1
No related works found for this paper.
Funding
- NSNational Science FoundationAwards: CA008748, P30 CA008748
- DRDamon Runyon Cancer Research FoundationAwards: P30 CA008748, DRQ-14-22
- ALAlex's Lemonade Stand Foundation for Childhood Cancer
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- AAstraZeneca
- SSanofi
- LALeukemia and Lymphoma SocietyAwards: CA066996, F32CA250240-02, CA176745, CA204639, CA206963, PE 3217/1-1
- GSGilead Sciences
- CCelgene
- MSMemorial Sloan-Kettering Cancer CenterAward: CA008748
- EPEdward P. Evans Foundation
- MKMerck KGaA
- PIParker Institute for Cancer Immunotherapy
- MFMark Foundation For Cancer Research
- FTFoghorn Therapeutics
- APAgios Pharmaceuticals
- CFCycle for SurvivalAwards: K08CA267058, P30 CA008748
- BPBoston Pharmaceuticals
- CBCTI Biopharma
- ETEntasis Therapeutics
- SPSyndax Pharmaceuticals
- RTRelay Therapeutics
- MMacroGenics
- XXtalPi
- DFDeutsche ForschungsgemeinschaftAwards: CA176745, PE 3217/1-1, F32CA250240-02, CA204639, P30 CA008748, CA206963, CA066996
- DDaiichi-SankyoAward: P30 CA008748
- EKElse Kröner-Fresenius-StiftungAward: 2021-EKEA.111
- EEisaiAward: P30 CA008748
- APAstellas Pharma
- SServier
- SCStiftung Charité
- NINational Institutes of HealthAwards: CA206963, CA173636, P30 CA008748, GM121505, PE 3217/1-1, CA176745, P50CA206963, CA214608, R01 GM121505, F32CA250240-02, CA204639, CA066996, R01GM121505
- GGenentechAward: P30 CA008748
- ESEMD Serono
- AAllergan
- NCNational Cancer InstituteAwards: R35 CA197594, CA066996, CA176745, CA008748, CA173636, P30 CA008748, CA214608, P50CA206963, R01 CA173636, CA204639